PharmaShots | Incisive News in 3 Shots

Subscribe Now

Combination Regimen

Janssen's Darzalex (daratumumab- SC) Combination Regimen Receives Health Canada's Approval for Patients with Newly Diagnosed Light Chain Amyloidosis

Janssen's Darzalex (daratumumab- SC) Combination Regimen Receives Health Canada's Approval for Patients with Newly Diagnosed Light...

April 20, 2021

Innovent and Eli Lilly Report sNDA Acceptance of Tyvyt (sintilimab) Combination Regimen as 1L Therapy in Squamous Non-Small Cell Lung Cancer in China

Innovent and Eli Lilly Report sNDA Acceptance of Tyvyt (sintilimab) Combination Regimen as 1L Therapy in Squamous Non-Small Cell L...

August 12, 2020

Noxopharm Collaborates with GenesisCare to Bring Combination Regimen of Veyonda (idronoxil) and Lu-PSMA in Australia

Noxopharm Collaborates with GenesisCare to Bring Combination Regimen of Veyonda (idronoxil) and Lu-PSMA in Australia

February 18, 2020

$Janssen Reports Submission of sBLA to the US FDA for Darzalex (daratumumab) based Combination Regimen for Relapsed/Refractory Multiple Myeloma$

Janssen Reports Submission of sBLA to the US FDA for Darzalex (daratumumab) based Combination Regimen for Relapsed/Refractory Mult...

February 11, 2020

Roche's Polivy (polatuzumab vedotin) Based Combination Regimen Receives EC's Approval for Patients with R/R Diffuse Large B-Cell Lymphoma

Roche's Polivy (polatuzumab vedotin) Based Combination Regimen Receives EC's Approval for Patients with R/R Diffuse Large B-Cell L...

January 21, 2020

Janssen's Darzalex (daratumumab) Combination Regimen Receives EC's Approval for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Janssen's Darzalex (daratumumab) Combination Regimen Receives EC's Approval for Transplant Eligible Patients with Newly Diagnosed...

January 21, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us